Cargando…
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis( )
AIMS: Targeting vascular inflammation represents a novel therapeutic approach to reduce complications of atherosclerosis. Neutralizing the pro-inflammatory cytokine interleukin-1β (IL-1β) using canakinumab, a monoclonal antibody, reduces the incidence of cardiovascular events in patients after myoca...
Autores principales: | Hettwer, Jan, Hinterdobler, Julia, Miritsch, Benedikt, Deutsch, Marcus-André, Li, Xinghai, Mauersberger, Carina, Moggio, Aldo, Braster, Quinte, Gram, Hermann, Robertson, Avril A B, Cooper, Matthew A, Groß, Olaf, Krane, Markus, Weber, Christian, Koenig, Wolfgang, Soehnlein, Oliver, Adamstein, Nicholas H, Ridker, Paul, Schunkert, Heribert, Libby, Peter, Kessler, Thorsten, Sager, Hendrik B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586563/ https://www.ncbi.nlm.nih.gov/pubmed/34718444 http://dx.doi.org/10.1093/cvr/cvab337 |
Ejemplares similares
-
Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation
por: Meyer-Lindemann, Ulrike, et al.
Publicado: (2022) -
Where the Action Is—Leukocyte Recruitment in Atherosclerosis
por: Mauersberger, Carina, et al.
Publicado: (2022) -
Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis
por: Hinterdobler, Julia, et al.
Publicado: (2021) -
Impact of Acute and Chronic Psychosocial Stress on Vascular Inflammation
por: Hinterdobler, Julia, et al.
Publicado: (2021) -
Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
por: Moggio, Aldo, et al.
Publicado: (2022)